Ascend Wellness Holdings (AAWH) Equity Average (2020 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly Equity Average of -$62.0 million in Q1 2026, down 176.47% quarter-over-quarter from -$22.4 million in Q4 2025, and down 199.62% on a YoY basis from $62.2 million in Q1 2025.
Ascend Wellness Holdings (AAWH) Equity Average (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Equity Average history runs 7 years deep, the most recent figure standing at -$62.0 million for Q1 2026.
- In Q1 2026, Equity Average fell 199.62% year-over-year to -$62.0 million; the TTM figure through Mar 2026 stood at -$62.0 million (down 199.62% YoY), while the FY2025 annual figure was $12.2 million, down 88.65% from the prior year.
- Equity Average was -$62.0 million for Q1 2026 at Ascend Wellness Holdings, down from -$22.4 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $180.3 million in Q3 2022 to a low of -$62.0 million in Q1 2026.
- Historically, Equity Average has averaged $105.8 million across 5 years, with a median of $139.4 million in 2024.
- The sharpest annual moves came in 2022 and 2026: Equity Average surged 3216.58% in 2022, then sank 199.62% in 2026.
- A 5-year view of Equity Average shows it stood at $168.7 million in 2022, then dropped by 10.41% to $151.2 million in 2023, then plunged by 46.84% to $80.4 million in 2024, then plunged by 127.91% to -$22.4 million in 2025, then plunged by 176.47% to -$62.0 million in 2026.
- The last three Equity Average figures came in at -$62.0 million (Q1 2026), -$22.4 million (Q4 2025), and $15.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 493.55 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.15 Bn |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn | -62.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62.02 Mn |
| Dec 31, 2025 | -22.43 Mn |
| Sep 30, 2025 | 15.37 Mn |
| Jun 30, 2025 | 40.43 Mn |
| Mar 31, 2025 | 62.25 Mn |
| Dec 31, 2024 | 80.36 Mn |
| Sep 30, 2024 | 103.23 Mn |
| Jun 30, 2024 | 126.69 Mn |
| Mar 31, 2024 | 139.35 Mn |
| Dec 31, 2023 | 151.17 Mn |
| Sep 30, 2023 | 162.71 Mn |
| Jun 30, 2023 | 157.46 Mn |
| Mar 31, 2023 | 156.19 Mn |
| Dec 31, 2022 | 168.74 Mn |
| Sep 30, 2022 | 180.34 Mn |
| Jun 30, 2022 | 172.32 Mn |
| Mar 31, 2022 | 167.25 Mn |
| Dec 31, 2021 | 180.26 Mn |
| Sep 30, 2021 | 186.68 Mn |
| Jun 30, 2021 | 87.40 Mn |